Wordt geladen...
RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine
BACKGROUND: Fusion genes form as a result of abnormal chromosomal rearrangements linking previously separate genes into one transcript. The FGFR3-TACC3 fusion gene (F3-T3) has been shown to drive gliomagenesis in glioblastoma (GBM), a cancer that is notoriously resistant to therapy. However, success...
Bewaard in:
| Gepubliceerd in: | Neurooncol Adv |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680176/ https://ncbi.nlm.nih.gov/pubmed/33241214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa132 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|